2nd Quarter - Report

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act (entire bill); H.R. 1957, Veterans Infertility Treatment Act (entire bill); H.R. 2670, the National Defense Authorization Act for Fiscal Year 2024 (issues related to fertility access for the military); Expanding Access to Fertility Care for Servicemembers and Dependents Act (Reintroduction in 118th Congress); Pandemic and All Hazards Preparedness Act (PAHPA) (entire bill; no bill number).

LobbyistCovered position, as disclosed
TIMOTHY CLARK New —
TEGAN GELFAND —
TIFFANY SHACKELFORD —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1957 (118th), H.R. 4450 (118th), H.R. 2670 (118th), S. 2352 (118th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.